Regulation of P-TEFb Elongation Complex Activity by CDK9 Acetylation

ABSTRACT P-TEFb, comprised of CDK9 and a cyclin T subunit, is a global transcriptional elongation factor important for most RNA polymerase II (pol II) transcription. P-TEFb facilitates transcription elongation in part by phosphorylating Ser2 of the heptapeptide repeat of the carboxy-terminal domain (CTD) of the largest subunit of pol II. Previous studies have shown that P-TEFb is subjected to negative regulation by forming an inactive complex with 7SK small RNA and HEXIM1. In an effort to investigate the molecular mechanism by which corepressor N-CoR mediates transcription repression, we identified HEXIM1 as an N-CoR-interacting protein. This finding led us to test whether the P-TEFb complex is regulated by acetylation. We demonstrate that CDK9 is an acetylated protein in cells and can be acetylated by p300 in vitro. Through both in vitro and in vivo assays, we identified lysine 44 of CDK9 as a major acetylation site. We present evidence that CDK9 is regulated by N-CoR and its associated HDAC3 and that acetylation of CDK9 affects its ability to phosphorylate the CTD of pol II. These results suggest that acetylation of CDK9 is an important posttranslational modification that is involved in regulating P-TEFb transcriptional elongation function.

[1]  T. Kiss,et al.  Regulation of Polymerase II Transcription by 7SK snRNA: Two Distinct RNA Elements Direct P-TEFb and HEXIM1 Binding , 2006, Molecular and Cellular Biology.

[2]  E. Seto,et al.  Acetylation and deacetylation of non-histone proteins. , 2005, Gene.

[3]  Sharon Y. R. Dent,et al.  Histone modifying enzymes and cancer: Going beyond histones , 2005, Journal of cellular biochemistry.

[4]  Qiang Zhou,et al.  Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. , 2005, Molecular cell.

[5]  J. Brady,et al.  The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. , 2005, Molecular cell.

[6]  Dongmei Cheng,et al.  Analysis of the Large Inactive P-TEFb Complex Indicates That It Contains One 7SK Molecule, a Dimer of HEXIM1 or HEXIM2, and Two P-TEFb Molecules Containing Cdk9 Phosphorylated at Threonine 186* , 2005, Journal of Biological Chemistry.

[7]  J. Wong,et al.  JMJD2A Is a Novel N-CoR-Interacting Protein and Is Involved in Repression of the Human Transcription Factor Achaete Scute-Like Homologue 2 (ASCL2/Hash2) , 2005, Molecular and Cellular Biology.

[8]  Danny Reinberg,et al.  Elongation by RNA polymerase II: the short and long of it. , 2004, Genes & development.

[9]  W. Craigen,et al.  Activation of cardiac Cdk9 represses PGC‐1 and confers a predisposition to heart failure , 2004, The EMBO journal.

[10]  X. Graña,et al.  Cellular control of gene expression by T-type cyclin/CDK9 complexes. , 2004, Gene.

[11]  Van Trung Nguyen,et al.  Binding of the 7SK snRNA turns the HEXIM1 protein into a P‐TEFb (CDK9/cyclin T) inhibitor , 2004, The EMBO journal.

[12]  R. Roeder,et al.  Regulation of the p300 HAT domain via a novel activation loop , 2004, Nature Structural &Molecular Biology.

[13]  Y. Kanno,et al.  Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. , 2004, Molecular cell.

[14]  O. Bensaude,et al.  MAQ1 and 7SK RNA Interact with CDK9/Cyclin T Complexes in a Transcription-Dependent Manner , 2003, Molecular and Cellular Biology.

[15]  A. Link,et al.  Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. , 2003, Molecular cell.

[16]  L. Lania,et al.  Catalytic activity of Cdk9 is required for nuclear co‐localization of the Cdk9/cyclin T1 (P‐TEFb) complex , 2003, Journal of cellular physiology.

[17]  Jun Qin,et al.  N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. , 2003, Molecular cell.

[18]  M. Lazar,et al.  The N-CoR/Histone Deacetylase 3 Complex Is Required for Repression by Thyroid Hormone Receptor , 2003, Molecular and Cellular Biology.

[19]  Tom Misteli,et al.  The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  O. Bensaude,et al.  MAQ1 and 7SK RNA Interact with CDK9/Cyclin T Complexes in a Transcription-Dependent Manner , 2003, Molecular and Cellular Biology.

[21]  Jun Qin,et al.  Purification and functional characterization of the human N‐CoR complex: the roles of HDAC3, TBL1 and TBLR1 , 2003, The EMBO journal.

[22]  A. Giordano,et al.  Activation and function of cyclin T–Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy , 2002, Nature Medicine.

[23]  J. Greenblatt,et al.  Regulation of transcription elongation by phosphorylation. , 2002, Biochimica et biophysica acta.

[24]  Yang Shi,et al.  CDK-9/cyclin T (P-TEFb) is required in two postinitiation pathways for transcription in the C. elegans embryo. , 2002, Genes & development.

[25]  Brian T Chait,et al.  The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. , 2002, Molecular cell.

[26]  Ming-Ming Zhou,et al.  Bromodomain: an acetyl‐lysine binding domain , 2002, FEBS letters.

[27]  B. Peterlin,et al.  Interaction between P-TEFb and the C-Terminal Domain of RNA Polymerase II Activates Transcriptional Elongation from Sites Upstream or Downstream of Target Genes , 2002, Molecular and Cellular Biology.

[28]  Tamás Kiss,et al.  7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes , 2001, Nature.

[29]  Qiang Zhou,et al.  The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription , 2001, Nature.

[30]  M. Guenther,et al.  The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3 , 2001, Molecular and Cellular Biology.

[31]  D. Price,et al.  Flavopiridol Inactivates P-TEFb and Blocks Most RNA Polymerase II Transcription in Vivo * , 2001, The Journal of Biological Chemistry.

[32]  E. Sausville,et al.  Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication* , 2000, The Journal of Biological Chemistry.

[33]  J. Qin,et al.  Both corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3 , 2000, The EMBO journal.

[34]  C. Glass,et al.  The histone deacetylase-3 complex contains nuclear receptor corepressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Shiekhattar,et al.  A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. , 2000, Genes & Development.

[36]  R. Gaynor,et al.  Domains in the SPT5 Protein That Modulate Its Transcriptional Regulatory Properties , 2000, Molecular and Cellular Biology.

[37]  R. Tjian,et al.  Structure and function of a human TAFII250 double bromodomain module. , 2000, Science.

[38]  J. Wong,et al.  p300 Requires Its Histone Acetyltransferase Activity and SRC-1 Interaction Domain To Facilitate Thyroid Hormone Receptor Activation in Chromatin , 2000, Molecular and Cellular Biology.

[39]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[40]  R. Evans,et al.  Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. , 2000, Genes & development.

[41]  E. Miska,et al.  Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. , 2000, Genes & development.

[42]  A. Giordano,et al.  Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo , 1999, Oncogene.

[43]  B. Cullen,et al.  Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Hazuda,et al.  Host-cell positive transcription elongation factor b kinase activity is essential and limiting for HIV type 1 replication. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Hiroshi Handa,et al.  NELF, a Multisubunit Complex Containing RD, Cooperates with DSIF to Repress RNA Polymerase II Elongation , 1999, Cell.

[46]  H. Stunnenberg,et al.  Leukemic transformation by the v‐ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo , 1998, The EMBO journal.

[47]  H. Handa,et al.  Evidence that P‐TEFb alleviates the negative effect of DSIF on RNA polymerase II‐dependent transcription in vitro , 1998, The EMBO journal.

[48]  A. Giordano,et al.  CDK9 (PITALRE): A multifunctional cdc2‐related kinase , 1998, Journal of cellular physiology.

[49]  A. Rice,et al.  Tat-Associated Kinase, TAK, Activity Is Regulated by Distinct Mechanisms in Peripheral Blood Lymphocytes and Promonocytic Cell Lines , 1998, Journal of Virology.

[50]  B. Peterlin,et al.  The Ability of Positive Transcription Elongation Factor b To Transactivate Human Immunodeficiency Virus Transcription Depends on a Functional Kinase Domain, Cyclin T1, and Tat , 1998, Journal of Virology.

[51]  D. Chen,et al.  Transcription elongation factor P‐TEFb mediates Tat activation of HIV‐1 transcription at multiple stages , 1998, The EMBO journal.

[52]  D. Price,et al.  Identification of a Cyclin Subunit Required for the Function ofDrosophila P-TEFb* , 1998, The Journal of Biological Chemistry.

[53]  J. Milton,et al.  Identification of multiple cyclin subunits of human P-TEFb. , 1998, Genes & development.

[54]  A. Wolffe,et al.  Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase , 1998, The EMBO journal.

[55]  M. Mathews,et al.  Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. , 1997, Genes & development.

[56]  S. Schreiber,et al.  Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.

[57]  C. Glass,et al.  A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression , 1997, nature.

[58]  D. Price,et al.  Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.

[59]  Thorsten Heinzel,et al.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.

[60]  R. Evans,et al.  A transcriptional co-repressor that interacts with nuclear hormone receptors , 1995, Nature.

[61]  D. Price,et al.  Purification of P-TEFb, a Transcription Factor Required for the Transition into Productive Elongation (*) , 1995, The Journal of Biological Chemistry.

[62]  M. Dahmus.  Phosphorylation of the C-terminal domain of RNA polymerase II. , 1995, Biochimica et biophysica acta.

[63]  A. Rice,et al.  Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor , 1995, Journal of virology.

[64]  P. Sharp,et al.  5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. , 1989, The Journal of biological chemistry.

[65]  B. Peterlin,et al.  Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.